Meet Lisa Vuich, MD

Dr. Vuich graduated from Tufts University in 1988 and Tufts University School of Medicine in 1992. She completed her Internal Medicine Internship and Residency at St. Vincent Hospital (University of Massachusetts affiliate) in 1995 and was Chief Medical Resident there from 1995 to 1996.

She is Board Certified by the American Academy of Aesthetic Medicine and is a member of the American MedAesthetic Association, the American Academy of Anti-Aging Medicine. the InjectAbility® Institute, and StudioPRP.

She is a Key Opinion Leader for several aesthetic device companies and is a founding member of the Bridging Biosciences Advisory Board which is working to develop new technologies for quality control and outcomes measurements for cell therapies such as platelet-rich plasma. Dr. Vuich is the Lead Clinical Investigator for a Clinical Trial: Quantitative platelet count analysis of pre- and post- centrifugation in a real- world clinical setting- PROTOCOL NO: BB-IP-AS-01 VERSION: 1.1 IRB Approval Date: June 21, 2018 –Sponsor: Bridging Biosciences, LLC

Dr. Vuich is a master trainer for the  Specialty Med Training group, teaching other physicians and nurse injectors how to perform these advanced regenerative procedures at the Renew MediSpa Training Institute and at various other locations throughout the year.

 

 

 

 

 

 

She has also trained in England under Prof. Bob Khanna in advanced injection techniques and thread lifting.

“Just looking at my staff, who all receive their services at Renew, it should be evident to anyone that our aesthetic goal is to achieve a balanced, natural looking, not over done facial rejuvenation. The key to this is often combination therapies, which we have mastered. Our additional expertise in the field of sexual wellness is unmatched in the area. We look forward to helping you look and function your best at any age. ” – Dr. Lisa Vuich

Renew MediSpa has been honored with the distinction of Best Spa Award, Hippo Magazine 2015, 2016, 2017, and Best of the Best Spas in 2018.